| International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies N Agmon-Levin, J Damoiseaux, C Kallenberg, U Sack, T Witte, M Herold, ... Annals of the rheumatic diseases 73 (1), 17-23, 2014 | 716 | 2014 |
| Effect of the interleukin-6 promoter polymorphism (− 174 G/C) on the incidence and outcome of sepsis B Schlüter, C Raufhake, M Erren, H Schotte, F Kipp, S Rust, H Van Aken, ... Critical care medicine 30 (1), 32-37, 2002 | 263 | 2002 |
| Interleukin 6—a potential mediator of lethal sepsis after major thermal trauma: evidence for increased IL-6 production by peripheral blood mononuclear cells B SCHLÜTER, B KÖNIG, UWE Bergmann, FE MÜLLER, W KÖNIG Journal of Trauma and Acute Care Surgery 31 (12), 1663-1670, 1991 | 173 | 1991 |
| The human ABCG4 gene is regulated by oxysterols and retinoids in monocyte-derived macrophages T Engel, S Lorkowski, A Lueken, S Rust, B Schlüter, G Berger, P Cullen, ... Biochemical and biophysical research communications 288 (2), 483-488, 2001 | 137 | 2001 |
| Reversible cardiac sympathectomy by high thoracic epidural anesthesia improves regional left ventricular function in patients undergoing coronary artery bypass grafting: a … E Berendes, C Schmidt, H Van Aken, MG Hartlage, S Wirtz, H Reinecke, ... Archives of Surgery 138 (12), 1283-1290, 2003 | 126 | 2003 |
| Clinical utility of the anti‐CCP assay: experiences with 700 patients U Sauerland, H Becker, M Seidel, H Schotte, P Willeke, A Schorat, ... Annals of the New York Academy of Sciences 1050 (1), 314-318, 2005 | 119 | 2005 |
| Interleukin‐6 promoter polymorphism (− 174 G/C) in Caucasian German patients with systemic lupus erythematosus H Schotte, B Schluter, S Rust, G Assmann, W Domschke, M Gaubitz Rheumatology 40 (4), 393-400, 2001 | 107 | 2001 |
| Mycophenolate sodium treatment in patients with primary Sjögren syndrome: a pilot trial P Willeke, B Schlüter, H Becker, H Schotte, W Domschke, M Gaubitz Arthritis research & therapy 9, 1-7, 2007 | 96 | 2007 |
| Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus T Fassbinder, U Saunders, E Mickholz, E Jung, H Becker, B Schlüter, ... Arthritis research & therapy 17, 1-12, 2015 | 84 | 2015 |
| Early identification of peritonitis by peritoneal cytokine measurement R Herwig, B Glodny, C Kühle, B Schlüter, OA Brinkmann, H Strasser, ... Diseases of the colon & rectum 45, 514-521, 2002 | 84 | 2002 |
| ADP-ribosylation factor (ARF)-like 7 (ARL7) is induced by cholesterol loading and participates in apolipoprotein AI-dependent cholesterol export T Engel, A Lueken, G Bode, U Hobohm, S Lorkowski, B Schlueter, S Rust, ... FEBS letters 566 (1-3), 241-246, 2004 | 79 | 2004 |
| Interleukin 1β and tumour necrosis factor α secreting cells are increased in the peripheral blood of patients with primary Sjögren’s syndrome P Willeke, H Schotte, B Schlüter, M Erren, H Becker, A Dyong, E Mickholz, ... Annals of the rheumatic diseases 62 (4), 359-361, 2003 | 71 | 2003 |
| Interleukin 10 promoter microsatellite polymorphisms are associated with response to long term treatment with etanercept in patients with rheumatoid arthritis H Schotte, B Schlüter, S Drynda, P Willeke, N Tidow, G Assmann, ... Annals of the rheumatic diseases 64 (4), 575-581, 2005 | 69 | 2005 |
| Lack of association between the–260 C→ T promoter polymorphism of the endotoxin receptor CD14 gene and the CD14 density of unstimulated human monocytes and soluble CD14 plasma … M Heesen, B Blömeke, B Schlüter, N Heussen, R Rossaint, D Kunz Intensive care medicine 27, 1770-1775, 2001 | 60 | 2001 |
| Differential regulation of T-and B-lymphocyte activation in severely burned patients B SCHLÜTER, W KÖNIG, M KÖLLER, G ERBS, FE MÜLLER Journal of Trauma and Acute Care Surgery 31 (2), 239-246, 1991 | 59 | 1991 |
| Leukotriene generation and metabolism in isolated human lung macrophages. W Schönfeld, B Schlüter, R Hilger, W König Immunology 65 (4), 529, 1988 | 58 | 1988 |
| Long-term treatment with etanercept significantly reduces the number of proinflammatory cytokine-secreting peripheral blood mononuclear cells in patients with rheumatoid arthritis H Schotte, B Schluter, P Willeke, E Mickholz, MA Schorat, W Domschke, ... Rheumatology 43 (8), 960-964, 2004 | 54 | 2004 |
| Platelet counts as a biomarker in ANCA-associated vasculitis P Willeke, P Kümpers, B Schlüter, A Limani, H Becker, H Schotte Scandinavian Journal of Rheumatology 44 (4), 302-308, 2015 | 44 | 2015 |
| Infliximab-induced lupus erythematosus tumidus in a patient with rheumatoid arthritis SW Schneider, S Staender, B Schlüter, TA Luger, G Bonsmann Archives of dermatology 142 (1), 109-116, 2006 | 44 | 2006 |
| Clinical and immunological characteristics of patients with Sjögren's syndrome in relation to α-fodrin antibodies P Willeke, M Gaubitz, H Schotte, H Becker, E Mickholz, W Domschke, ... Rheumatology 46 (3), 479-483, 2007 | 38 | 2007 |
